Patents Assigned to Buddhist Tzu Chi Medical Foundation
-
Patent number: 11963969Abstract: Provided is a pharmaceutical composition including gastrodin and a use thereof for the prevention or the treatment of amyotrophic lateral sclerosis. The pharmaceutical composition is effective in reducing neuronal axon degeneration and neurofibromin accumulation, improving symptoms of amyotrophic lateral sclerosis and extending life of patients of amyotrophic lateral sclerosis.Type: GrantFiled: September 16, 2022Date of Patent: April 23, 2024Assignee: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Chia-Yu Chang, Shinn-Zong Lin, Hsiao-Chien Ting, Hui-I Yang, Horng-Jyh Harn, Hong-Lin Su, Ching-Ann Liu, Yu-Shuan Chen, Tzyy-Wen Chiou, Tsung-Jung Ho
-
Patent number: 11771548Abstract: Provided is a surgical instrument including a first holding member, a sleeve member, a linkage member, a second holding member, a hook member and an opening/closing member. The second holding member is pivotally connected to the first holding member and when the second holding member moves relative to the first holding member, the linkage member is moved inside the sleeve member so as to drive the opening/closing member to move relative to the hook member. Through the movement of the opening/closing member of the surgical instrument, surrounding soft tissues, blood vessels or nerves that have strayed into the hook member can be pushed out so as not to be damaged by the hook member during surgery.Type: GrantFiled: April 7, 2021Date of Patent: October 3, 2023Assignee: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventor: Chen-Chie Wang
-
Patent number: 11752151Abstract: Provided is a method for enhancing hair growth through modulating a hair follicle cycle in a subject in need thereof. The method includes inhibition of casein kinase 1? in an area of skin in the subject. Also provided is a method for increasing hair pigmentation in a subject in need thereof.Type: GrantFiled: July 12, 2021Date of Patent: September 12, 2023Assignee: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventor: Chung-Hsing Chang
-
Publication number: 20230149678Abstract: Provided is a device for transdermal delivery of drugs. The device includes a separable substrate and is loaded with dual drugs based on an interpenetrating polymer network hydrogel. Also provided are methods of making and using the transdermal delivery device.Type: ApplicationFiled: November 12, 2021Publication date: May 18, 2023Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Yu-Shuan Chen, Hsieh-Chih Tsai, Chang-Yi Lee, Haile Fentahun Darge, Shinn-Zong Lin, Tzyy-Wen Chiou, Chia-Yu Chang
-
Publication number: 20230059769Abstract: A facial skin disorder (FSD) identification system is provided and includes a sliding rail arranged around a human facial epidermis, a carrier arranged on the sliding rail, at least one image capturing device arranged on the carrier, and a control circuit unit arranged on the carrier for the carrier to move on the sliding rail and the image capturing device to capture images of the human facial epidermis.Type: ApplicationFiled: January 27, 2022Publication date: February 23, 2023Applicants: BUDDHIST TZU CHI MEDICAL FOUNDATION, NATIONAL APPLIED RESEARCH LABORATORIESInventors: Chung-Hsing Chang, Shinn-Zong Lin, Chun-Ming Chang, Nai-Yuan Chiang, Rou-Jhen Chen, Han-Chao Chang
-
Patent number: 11365200Abstract: The invention relates to compounds for treating and/or preventing obesity and obesity-related disorders. Particularly, the invention provides chromanone derivatives used as ATF3 inducer and for treating and/or preventing obesity and obesity-related disorders such as heart disease, hypertension, hyperlipidemia and diabetes.Type: GrantFiled: March 22, 2018Date of Patent: June 21, 2022Assignees: TAIPEI MEDICAL UNIVERSITY, NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE, ACADEMIA SINICA, BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Heng Lin, Ming-jaw Don, Ching-feng Cheng, Jing-jy Cheng, Wen-shan Li, Hui-chen Ku, Hsiao-fen Li, Hsi-hsien Chen, W J Huang
-
Publication number: 20220096431Abstract: Provided is a pharmaceutical composition and method for preventing, treating and diagnosing a neurodegenerative disease in a subject in need thereof. The method includes obtaining a biological sample from the subject and determining an expression level of a miRNA, and stimulating expression of the miRNA. Also provided is a kit for diagnosing a neurodegenerative disease in a subject in need thereof.Type: ApplicationFiled: September 30, 2021Publication date: March 31, 2022Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou, Wei Wuli
-
Publication number: 20210301318Abstract: The present invention relates to a biomarker and target for diagnosis, prognosis and treatment of ankylosing spondylitis (AS). The present invention also relates to a method for producing an animal model for AS, an animal model produced therefrom, and a method for screening for an agent pharmaceutically active in the treatment of A S using such animal model.Type: ApplicationFiled: July 10, 2019Publication date: September 30, 2021Applicants: ACADEMIA SINICA, BUDDHIST TZU CHI MEDICAL FOUNDATION, CHINA MEDICAL UNIVERSITYInventors: Kuo-I LIN, Shih-Chieh HUNG, Chin-Hsiu LIU
-
Patent number: 11045264Abstract: The present invention provides a handheld robot for orthopedic surgery and a control method thereof. The handheld robot of the present invention includes a main body, a grip, a kinematic mechanism, a tool connector, a tool, a force sensor and a positioning unit. The handheld robot of the present invention combines the position/orientation information of the tool acquired by the positioning unit with the force/torque information acquired by the force sensor, and utilizes the combined information to adjust the position of the tool so as to keep the tool within the range/path of a predetermined operation plan. In this way, the precision of the orthopedic surgery can be enhanced, and the error occurred during the surgery can be minimized.Type: GrantFiled: January 4, 2017Date of Patent: June 29, 2021Assignees: NATIONAL TAIWAN UNIVERSITY, TAIPEI TZU CHI HOSPITAL, BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Ping-Lang Yen, Shuo-Suei Hung
-
Publication number: 20200261508Abstract: The present invention provides a pharmaceutical composition comprising mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier. The pharmaceutical composition is used for the treatment of the joint disease. The mesenchymal stem cells in the composition are at least one selected from the group consisting of infra-patellar fat pad stromal cells, bone marrow stem cells, Wharton's jelly stem cells and adipose derived stem cells. The concentration of the hyaluronan is in a range from 25% (v/v) to 75% (v/v). The present invention further provides a method for treating a joint disease, comprising a step of administrating a composition containing mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier to an injured joint tissue of a subject.Type: ApplicationFiled: March 17, 2020Publication date: August 20, 2020Applicant: Buddhist Tzu Chi Medical FoundationInventors: Dah-Ching Ding, Kun-Chi Wu
-
Patent number: 10624928Abstract: The present invention provides a pharmaceutical composition comprising mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier. The pharmaceutical composition is used for the treatment of the joint disease. The mesenchymal stem cells in the composition are at least one selected from the group consisting of infra-patellar fat pad stromal cells, bone marrow stem cells, Wharton's jelly stem cells and adipose derived stem cells. The concentration of the hyaluronan is in a range from 25% (v/v) to 75% (v/v). The present invention further provides a method for treating a joint disease, comprising a step of administrating a composition containing mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier to an injured joint tissue of a subject.Type: GrantFiled: May 11, 2015Date of Patent: April 21, 2020Assignee: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationInventors: Dah-Ching Ding, Kun-Chi Wu
-
Patent number: 10465167Abstract: An adjuvant for rapid proliferation of human mesenchymal stem cells in vitro is provided to overcome the problem of low cell amplification efficiency of human mesenchymal stem cells in a culture process. The adjuvant added for the culture of human mesenchymal stem cells includes at least one antioxidant, and a basic fibroblast growth factor (FGF-2). The adjuvant is added into a medium containing the human mesenchymal stem cells, and the culture takes place in a normal oxygen environment (21% oxygen tension), and the cells are divided rapidly, and the cell cycle at synthesis phase (S phase) percentage is increased to reduce ageing and improve differentiation potential. The adjuvant not only amplifies human mesenchymal stem cells rapidly to harvest the growth factor, but also maintains the characteristics of the multifunction of stem cells for the purposes of culturing and amplifying the human mesenchymal stem cells.Type: GrantFiled: December 11, 2013Date of Patent: November 5, 2019Assignee: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationInventors: Li-Yi Sun, Cheng-Yoong Pang, Ching-Feng Cheng, Dian-Kun Li
-
Publication number: 20190298664Abstract: This disclosure provides method and kit for myocardial reperfusion and method for attenuating or reducing myocardial reperfusion injury. By administering protein tyrosine phosphatases inhibitor or a protein tyrosine kinases activator, cardiac injury caused by ischemia/reperfusion will be attenuated or reduced.Type: ApplicationFiled: March 28, 2019Publication date: October 3, 2019Applicants: Academia Sinica, Buddhist Tzu Chi Medical FoundationInventors: Tzu-Ching Meng, Chiu-Fen Yang, Michael Yu-Chih Chen
-
Patent number: 9856454Abstract: A method for rapid mincing of adipose tissues to isolate live cells in vitro is disclosed to overcome the drawbacks of a lead procedure of isolating live cells by holding a knife to mince adipose tissues, which can only isolate a small number of live cells and obtain low cell viability. The method includes: providing an adipose tissue; mincing the adipose tissue homogeneously by a mincing device; adding a reagent into the minced adipose tissue to perform hydrolysis; performing centrifuge and isolation; and removing a supernatant to obtain a cell pellet. Therefore, the time of mincing adipose tissues can be shortened, and contaminations caused by repeated use of the knife can be avoided. The method can be used for isolating live cells of adipose tissues to improve the number of live cells per unit weight of adipose tissues without reducing the cell viability.Type: GrantFiled: February 27, 2014Date of Patent: January 2, 2018Assignee: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationInventors: Li-Yi Sun, Dian-Kun Li, Cheng-Yoong Pang, Yao-Jen Chang
-
Patent number: 9574175Abstract: An endometrial polyp stem cell is disclosed in the present invention. The endometrial polyp stem cell is isolated from an endometrial polyp tissue, expresses vimentin, CD13, CD29, CD44, and CD90, and has no expression of CD1q, CD3, CD34, and CD45.Type: GrantFiled: September 6, 2011Date of Patent: February 21, 2017Assignee: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationInventor: Dah-Ching Ding
-
Patent number: 9561082Abstract: The present invention provides a handheld robot for orthopedic surgery and a control method thereof. The handheld robot of the present invention includes a main body, a grip, a kinematic mechanism, a tool connector, a tool, a force sensor and a positioning unit. The handheld robot of the present invention combines the position/orientation information of the tool acquired by the positioning unit with the force/torque information acquired by the force sensor, and utilizes the combined information to adjust the position of the tool so as to keep the tool within the range/path of a predetermined operation plan. In this way, the precision of the orthopedic surgery can be enhanced, and the error occurred during the surgery can be minimized.Type: GrantFiled: March 28, 2014Date of Patent: February 7, 2017Assignees: NATIONAL TAIWAN UNIVERSITY, TAIPEI TZU CHI HOSPITAL, BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Ping-Lang Yen, Shuo-Suei Hung
-
Publication number: 20160355782Abstract: A method for enhancing differentiation of dopaminergic (DA) neurons is provided. The method of the present invention includes culturing precursor cells; administering urocortin to the precursor cells; and differentiating the precursor cells into the DA neurons.Type: ApplicationFiled: June 8, 2015Publication date: December 8, 2016Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Mei-Jen Wang, Hsin-Yi Huang, Tsung-Lang Chiu, Hui-Fen Chang, Hui-Ru Hsu, Cheng-Yoong Pang, Hock-Kean Liew
-
Publication number: 20160095886Abstract: The present invention provides a pharmaceutical composition comprising mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier. The pharmaceutical composition is used for the treatment of the joint disease. The mesenchymal stem cells in the composition are at least one selected from the group consisting of infra-patellar fat pad stromal cells, bone marrow stem cells, Wharton's jelly stem cells and adipose derived stem cells. The concentration of the hyaluronan is in a range from 25% (v/v) to 75% (v/v). The present invention further provides a method for treating a joint disease, comprising a step of administrating a composition containing mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier to an injured joint tissue of a subject.Type: ApplicationFiled: May 11, 2015Publication date: April 7, 2016Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: Dah-Ching Ding, Kun-Chi Wu
-
Publication number: 20150266945Abstract: A method of delivering antigenic peptide into the endoplasmic reticulum by the fusion protein includes: (a) preparing a fusion protein with a Tat-derived peptide, a (His)6 peptide, a ubiquitin, and an antigenic peptide provided in turn from the N-terminal end to the C-terminal end; (b) delivering the fusion protein across the cell membrane into the cytosol through the Tat-derived peptide; (c) cleaving the antigenic peptide from the fusion protein by cytosolic ubiquitin C-terminal hydrolases; and (d) transporting the antigenic peptide into the endoplasmic reticulum (ER) by a TAP1/2 transporter on the ER membrane.Type: ApplicationFiled: March 21, 2014Publication date: September 24, 2015Applicant: Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationInventors: Ning-Sheng LAI, Hsien-Bin HUANG, Hui-Chun YU
-
Publication number: 20150240210Abstract: A method for rapid mincing of adipose tissues to isolate live cells in vitro is disclosed to overcome the drawbacks of a lead procedure of isolating live cells by holding a knife to mince adipose tissues, which can only isolate a small number of live cells and obtain low cell viability. The method includes: providing an adipose tissue; mincing the adipose tissue homogeneously by a mincing device; adding a reagent into the minced adipose tissue to perform hydrolysis; performing centrifuge and isolation; and removing a supernatant to obtain a cell pellet. Therefore, the time of mincing adipose tissues can be shortened, and contaminations caused by repeated use of the knife can be avoided. The method can be used for isolating live cells of adipose tissues to improve the number of live cells per unit weight of adipose tissues without reducing the cell viability.Type: ApplicationFiled: February 27, 2014Publication date: August 27, 2015Applicant: BUDDHIST TZU CHI MEDICAL FOUNDATIONInventors: LI-YI SUN, DIAN-KUN LI, CHENG-YOONG PANG, YAO-JEN CHANG